In December 2025, Spanish researchers published their results in the journal Proceedings of the National Academy of Science.
They tested a treatment in which three different therapies are combined instead of using just one.
In a trial involving mice, the researchers succeeded in eliminating tumors without serious side effects.
The scientists believe the combination works better because cancer cells often become resistant when only one type of medication is used.
Also read: More hours of sleep may lead to weight loss, study shows
However, NDTV reports that the treatment has not yet been tested on humans. The researchers still lack the funding required to begin clinical trials.
Difficult to detect
Pancreatic cancer is one of the most serious forms of cancer. It is often detected late because symptoms can be mild in the early stages.
By the time the disease is discovered, it has in many cases already spread. This makes treatment difficult.
Traditional treatments have had limited effect, partly because tumors can develop resistance to medication.
Also read: Can plant-based diets provide enough protein? Experts have the answer
It is precisely this challenge that the new combination therapy aims to address.
The researcher behind the study
One of the leading figures behind the research is Mariano Barbacid.
According to Stop Cancer, he earned his PhD in Madrid in 1974 and has worked in cancer research for decades, including in the United States.
The treatment is still at the research stage. Only after it has been tested in humans can its potential impact on patients be assessed.
Also read: New cell discovery could change how we fight cancer and ALS
Sources: Green Matters, Proceedings of the National Academy of Science, and NDTV.
Also read: Approval of eye drops could impact millions with presbyopia